RARE

Ultragenyx Pharmaceutical Inc

May 19 • 04:00PM ET

22.45

-1.74 -7.19 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: PTCT BMRN SRPT KRYS CRSP

| Held by: XBI VTI VB VBK VXF IBB IWP SCHA IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.11	Insider Own	5.77%	Shs Outstand	98.00M	Perf Week	-16.36%
Market Cap	2.21B	Forward P/E	-	EPS next Y	-0.69	Insider Trans	-2.34%	Shs Float	92.80M	Perf Month	-10.41%
Enterprise Value	3.00B	PEG	-	EPS next Q	-1.22	Inst Own	97.95%	Short Float	14.73%	Perf Quarter	9.78%
Income	-609.36M	P/S	3.30	EPS this Y	22.78%	Inst Trans	-4.50%	Short Ratio	7.20	Perf Half Y	-32.13%
Sales	669.43M	P/B	-	EPS next Y	84.69%	ROA	-46.73%	Short Interest	13.67M	Perf YTD	-2.39%
Book/sh	-2.41	P/C	5.25	EPS next 5Y	-	ROE	-656.54%	52W High	42.37 -47.01%	Perf Year	-37.97%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	16.78% -13.72%	ROIC	-68.31%	52W Low	18.29 22.74%	Perf 3Y	-55.01%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.81% 19.95%	Gross Margin	78.49%	Volatility	5.10% 4.57%	Perf 5Y	-79.33%
Dividend TTM	-	EV/Sales	4.48	EPS Y/Y TTM	-3.82%	Oper. Margin	-83.92%	ATR (14)	1.16	Perf 10Y	-63.47%
Dividend Ex-Date	-	Quick Ratio	1.85	Sales Y/Y TTM	13.33%	Profit Margin	-91.03%	RSI (14)	35.38	Recom	1.32
Dividend Gr. 3/5Y	- -	Current Ratio	2.02	EPS Q/Q	-17.21%	SMA20	-10.23%	Beta	0.38	Target Price	51.42
Payout	-	Debt/Eq	-	Sales Q/Q	-2.36%	SMA50	-3.47%	Rel Volume	1.12	Prev Close	24.19
Employees	1371	LT Debt/Eq	-	Earnings	May 05 AMC	SMA200	-18.69%	Avg Volume	1.90M	Price	22.45
IPO	Jan 31, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.67% -14.03%	Trades		Volume	2,121,460	Change	-7.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)